Elevation Oncology, Inc. (ELEV) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts ELEV Hot Sheet
Join SI Premium – FREE
Elevation Oncology, Inc. (NASDAQ: ELEV) reported Q2 EPS of ($0.18), $0.04 better than the analyst estimate of ($0.22).
For earnings history and earnings-related data on Elevation Oncology, Inc. (ELEV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Slew of analyst comments sends Take-Two (TTWO) up 4% ahead of November earnings and GTV 6
- Meta releases Muse Spark Open, an 816B-parameter AI model
- EU ready to fast-track satellite rival to SpaceX - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
